| scholarly article | Q13442814 |
| P50 | author | Francesco Marangoni | Q56106795 |
| P2093 | author name string | Thorsten R Mempel | |
| Edward Y Kim | |||
| Esteban Carrizosa | |||
| Christian A Bauer | |||
| Natalie M Claudio | |||
| P2860 | cites work | FOXP3 controls regulatory T cell function through cooperation with NFAT | Q24298179 |
| Interleukin-2 Receptor Signaling: At the Interface between Tolerance and Immunity | Q24599806 | ||
| Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer | Q24633070 | ||
| Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4 | Q24634871 | ||
| T helper 17 cells promote cytotoxic T cell activation in tumor immunity | Q24646584 | ||
| Tumor-specific Th17-polarized cells eradicate large established melanoma | Q24648032 | ||
| Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction | Q24650734 | ||
| Molecular mechanisms of T cell co-stimulation and co-inhibition | Q26864888 | ||
| Tuning of antigen sensitivity by T cell receptor-dependent negative feedback controls T cell effector function in inflamed tissues | Q27310781 | ||
| Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer | Q27860857 | ||
| Adoptive immunotherapy for cancer: harnessing the T cell response | Q28262548 | ||
| Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes | Q28282689 | ||
| Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival | Q29547865 | ||
| How regulatory T cells work | Q29614262 | ||
| CTLA-4 control over Foxp3+ regulatory T cell function | Q29619413 | ||
| T cell exhaustion | Q29620463 | ||
| Regulatory T cells: mechanisms of differentiation and function | Q29620731 | ||
| Two-photon imaging of intratumoral CD8+ T cell cytotoxic activity during adoptive T cell therapy in mice | Q30481516 | ||
| Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice | Q30498716 | ||
| Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo | Q33723552 | ||
| Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired | Q34080914 | ||
| The basis for TCR-mediated regulation of the IL-2 receptor alpha chain gene: role of widely separated regulatory elements | Q34089393 | ||
| Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity | Q34161493 | ||
| Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen–specific CD8+ T cell dysfunction in melanoma patients | Q34161579 | ||
| T cell and APC dynamics in situ control the outcome of vaccination | Q34381612 | ||
| Tumor emergence is sensed by self-specific CD44hi memory Tregs that create a dominant tolerogenic environment for tumors in mice. | Q34610483 | ||
| Intravital microscopy: visualizing immunity in context | Q34649824 | ||
| Dynamic imaging of cancer growth and invasion: a modified skin-fold chamber model. | Q34657571 | ||
| CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells | Q34709777 | ||
| Regulatory T cells sequentially migrate from inflamed tissues to draining lymph nodes to suppress the alloimmune response. | Q34966662 | ||
| Exhaustion of tumor-specific CD8+ T cells in metastases from melanoma patients | Q35015778 | ||
| Complete correction of murine Artemis immunodeficiency by lentiviral vector-mediated gene transfer | Q35133845 | ||
| In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro | Q35171080 | ||
| Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase | Q35925641 | ||
| Random migration precedes stable target cell interactions of tumor-infiltrating T cells. | Q36228164 | ||
| In vivo imaging of cytotoxic T cell infiltration and elimination of a solid tumor | Q36229738 | ||
| Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa-generated induced Foxp3+ T reg cells | Q36278051 | ||
| Continuous activation of autoreactive CD4+ CD25+ regulatory T cells in the steady state. | Q36371658 | ||
| Cooperation between CD4+ and CD8+ T cells: when, where, and how. | Q36427362 | ||
| Aire-dependent thymic development of tumor-associated regulatory T cells | Q36754190 | ||
| Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation | Q36786930 | ||
| Tumor-associated macrophages subvert T-cell function and correlate with reduced survival in clear cell renal cell carcinoma | Q36849038 | ||
| CD8(+) T lymphocyte mobilization to virus-infected tissue requires CD4(+) T-cell help | Q37461871 | ||
| CCR7 provides localized access to IL-2 and defines homeostatically distinct regulatory T cell subsets | Q37483117 | ||
| Regulatory T cells in tumor immunity | Q37762224 | ||
| Multiple treg suppressive modules and their adaptability. | Q38023409 | ||
| Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. | Q38305613 | ||
| Intravital Imaging Reveals Distinct Dynamics for Natural Killer and CD8+ T Cells during Tumor Regression | Q39643562 | ||
| Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment | Q40130406 | ||
| Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentiation | Q40252525 | ||
| Primary antitumor immune response mediated by CD4+ T cells | Q40444553 | ||
| Tumor antigens recognized by T lymphocytes | Q40661131 | ||
| Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific | Q40910998 | ||
| Pathogenic T cells have a paradoxical protective effect in murine autoimmune diabetes by boosting Tregs. | Q41446869 | ||
| Thymic selection of CD8+ single positive cells with a class II major histocompatibility complex-restricted receptor | Q41902311 | ||
| The Transcription Factor NFAT Exhibits Signal Memory during Serial T Cell Interactions with Antigen-Presenting Cells | Q42218721 | ||
| CD4+ T-cell help in the tumor milieu is required for recruitment and cytolytic function of CD8+ T lymphocytes | Q42385826 | ||
| The initial phase of an immune response functions to activate regulatory T cells | Q42571413 | ||
| Adaptation of TCR repertoires to self-peptides in regulatory and nonregulatory CD4+ T cells | Q42621143 | ||
| Establishment of mouse colonic carcinoma cell lines with different metastatic properties | Q42800656 | ||
| Visualizing the course of antigen-specific CD8 and CD4 T cell responses to a growing tumor | Q43729529 | ||
| Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma. | Q45358316 | ||
| Effector function of human tumor-specific CD8 T cells in melanoma lesions: a state of local functional tolerance | Q47755230 | ||
| Tumor-Specific CD4+ T Cells Render the Tumor Environment Permissive for Infiltration by Low-Avidity CD8+ T Cells | Q61140251 | ||
| CD8(+) T cell-mediated spontaneous diabetes in neonatal mice | Q61140579 | ||
| Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide | Q73688337 | ||
| Origin of regulatory T cells with known specificity for antigen | Q74381747 | ||
| Tumor Induction of VEGF Promoter Activity in Stromal Cells | Q77349243 | ||
| Preferential recognition of self antigens despite normal thymic deletion of CD4(+)CD25(+) regulatory T cells | Q77584357 | ||
| Generation of CD4(+)CD25(+) regulatory T cells from autoreactive T cells simultaneously with their negative selection in the thymus and from nonautoreactive T cells by endogenous TCR expression | Q77995835 | ||
| Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors | Q80444910 | ||
| A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment | Q80726091 | ||
| Autoantigen-specific TGFbeta-induced Foxp3+ regulatory T cells prevent autoimmunity by inhibiting dendritic cells from activating autoreactive T cells | Q81317281 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2425-2440 | |
| P577 | publication date | 2014-05-08 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Dynamic Treg interactions with intratumoral APCs promote local CTL dysfunction | |
| P478 | volume | 124 |
| Q47194065 | ATP Release from Chemotherapy-Treated Dying Leukemia Cells Elicits an Immune Suppressive Effect by Increasing Regulatory T Cells and Tolerogenic Dendritic Cells. |
| Q57287562 | Accelerated, but not conventional, radiotherapy of murine B-cell lymphoma induces potent T cell-mediated remissions |
| Q55002808 | Autologous tumor cells/bacillus Calmette-Guérin/formalin-based novel breast cancer vaccine induces an immune antitumor response. |
| Q40066040 | Blockade of surface-bound TGF-β on regulatory T cells abrogates suppression of effector T cell function in the tumor microenvironment |
| Q89724967 | CCL22 Signaling in the Tumor Environment |
| Q30252696 | CD11c-Expressing Cells Affect Regulatory T Cell Behavior in the Meninges during Central Nervous System Infection |
| Q30605826 | CD28-CD80 interactions control regulatory T cell motility and immunological synapse formation |
| Q48185876 | CD4 and CD8 T lymphocyte interplay in controlling tumor growth |
| Q40081387 | CDK4/6 inhibition triggers anti-tumour immunity. |
| Q38601221 | CTLA-4/CD80 pathway regulates T cell infiltration into pancreatic cancer |
| Q38737924 | Cancer Immunotherapy: Whence and Whither |
| Q39313794 | Comparative Analysis of Immune Checkpoint Molecules and Their Potential Role in the Transmissible Tasmanian Devil Facial Tumor Disease. |
| Q38315880 | Controlling the fire--tissue-specific mechanisms of effector regulatory T-cell homing. |
| Q42660198 | Crosstalk between Regulatory T Cells and Tumor-Associated Dendritic Cells Negates Anti-tumor Immunity in Pancreatic Cancer |
| Q41016369 | Cytokine-induced killer cell therapy for modulating regulatory T cells in patients with non-small cell lung cancer |
| Q38779877 | Cytokines and metabolic factors regulate tumoricidal T-cell function during cancer immunotherapy |
| Q64268077 | Depleting T regulatory cells by targeting intracellular Foxp3 with a TCR mimic antibody |
| Q92066438 | Dynamic visualization of the whole process of cytotoxic T lymphocytes killing B16 tumor cells in vitro |
| Q37162527 | Graded Foxo1 activity in Treg cells differentiates tumour immunity from spontaneous autoimmunity. |
| Q93049115 | Guidance factors orchestrating regulatory T cell positioning in tissues during development, homeostasis, and response |
| Q38770814 | Harnessing co-stimulatory TNF receptors for cancer immunotherapy: Current approaches and future opportunities |
| Q39294822 | IDO, PTEN-expressing Tregs and control of antigen-presentation in the murine tumor microenvironment |
| Q46188870 | Identification and characterization of T reg-like cells in zebrafish |
| Q35141650 | Imaging regulatory T cell dynamics and CTLA4-mediated suppression of T cell priming |
| Q89556686 | Immune crosstalk in cancer progression and metastatic spread: a complex conversation |
| Q38648567 | Immune suppressive mechanisms in the tumor microenvironment |
| Q53270050 | Immunology: In the right place at the right time |
| Q35142851 | Immunomodulatory antibody therapy of cancer: the closer, the better |
| Q36173500 | Impact of a New Fusion Receptor on PD-1-Mediated Immunosuppression in Adoptive T Cell Therapy |
| Q37714428 | In Vivo Imaging Sheds Light on Immune Cell Migration and Function in Cancer. |
| Q26765009 | In vivo imaging in autoimmune diseases in the central nervous system |
| Q37520816 | Long-term intravital imaging of the multicolor-coded tumor microenvironment during combination immunotherapy |
| Q38779257 | Mechanisms of tumor escape in the context of the T-cell-inflamed and the non-T-cell-inflamed tumor microenvironment |
| Q91740193 | Modulation of regulatory T cell function and stability by co-inhibitory receptors |
| Q89472896 | Multidimensional communication in the microenvirons of glioblastoma |
| Q26823540 | New insights into the mechanisms of Treg function |
| Q38853680 | Pharmacological Modulation of Proton Channel Hv1 in Cancer Therapy: Future Perspectives. |
| Q49788536 | Phenotypic and Functional Properties of Tumor-Infiltrating Regulatory T Cells. |
| Q37277855 | Prevention of allograft rejection in heart transplantation through concurrent gene silencing of TLR and Kinase signaling pathways |
| Q92129582 | Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target? |
| Q46909626 | Requirement of Treg-intrinsic CTLA4/PKCη signaling pathway for suppressing tumor immunity |
| Q38809776 | Reversing T-cell Dysfunction and Exhaustion in Cancer |
| Q58795966 | SENP3 maintains the stability and function of regulatory T cells via BACH2 deSUMOylation |
| Q90024077 | Systematically understanding the immunity leading to CRPC progression |
| Q35371293 | T cell metabolic fitness in antitumor immunity |
| Q26865338 | T-cell exhaustion in allograft rejection and tolerance |
| Q36266506 | TIGIT predominantly regulates the immune response via regulatory T cells. |
| Q33715943 | Targeted calcium influx boosts cytotoxic T lymphocyte function in the tumour microenvironment. |
| Q92052884 | Targeting the CBM complex causes Treg cells to prime tumours for immune checkpoint therapy |
| Q38805897 | Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy |
| Q36879974 | The multifaceted role of CD4(+) T cells in CD8(+) T cell memory |
| Q88489714 | The opposing roles of CD4+ T cells in anti-tumour immunity |
| Q38445342 | The transcription factor NFAT promotes exhaustion of activated CD8⁺ T cells. |
| Q99711547 | To Remember or to Forget: The Role of Good and Bad Memories in Adoptive T Cell Therapy for Tumors |
| Q39367810 | Transcriptional and epigenetic regulation of T cell hyporesponsiveness |
| Q52584757 | Tumor Tolerance-Promoting Function of Regulatory T Cells Is Optimized by CD28, but Strictly Dependent on Calcineurin. |
| Q98290372 | Tumor microenvironment in chemoresistance, metastasis and immunotherapy of pancreatic cancer |
| Q30830664 | Tumor-infiltrating lymphocytes are dynamically desensitized to antigen but are maintained by homeostatic cytokine |
| Q90176787 | Unleashing Natural Killer Cells in the Tumor Microenvironment-The Next Generation of Immunotherapy? |
| Q92905101 | Unleashing Type-2 Dendritic Cells to Drive Protective Antitumor CD4+ T Cell Immunity |
| Q48293616 | Unlocking the Complexities of Tumor-Associated Regulatory T Cells. |
| Q39249455 | Viewing immune regulation as it happens: in vivo imaging for investigation of regulatory T-cell function. |
| Q30650963 | Visualization and tracking of tumour extracellular vesicle delivery and RNA translation using multiplexed reporters |
| Q33965597 | Visualizing T Cell Migration in situ |
Search more.